Pacira Pharm Inc (PCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PCRX | AZN | AMGN | GILD | BMY |
| Company | Pacira Pharm Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 23.32 | 183.79 | 332.99 | 131.01 | 56.18 |
| High | 23.68 | 185.81 | 334.19 | 134.86 | 56.49 |
| Low | 22.46 | 181.73 | 327.62 | 130.98 | 55.41 |
| Latest | 22.74 | 181.86 | 329.59 | 133.52 | 55.67 |
| Change | -0.41 | -0.99 | -2.11 | +2.19 | -0.49 |
| % Change | -1.77% | -0.54% | -0.64% | +1.67% | -0.87% |
| Volume | 895,900 | 2,106,700 | 1,918,800 | 5,384,900 | 8,390,800 |
| 20-Day Average Volume | 630,240 | 2,113,815 | 2,637,820 | 6,088,660 | 10,165,805 |
| Previous Close | 23.15 | 182.85 | 331.70 | 131.33 | 56.16 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 24.44 | 190.63 | 340.34 | 133.61 | 58.08 |
| 20-Day Raw Stochastic | 6.00% | 7.35% | 24.93% | 42.73% | 4.93% |
| 20-Day Relative Strength | 43.66 | 38.96 | 40.64 | 46.21 | 41.29 |
| Weighted Alpha | -10.89 | +24.57 | +15.59 | +24.93 | +18.08 |
| Today's Opinion | 24% Sell | 8% Sell | 8% Sell | 8% Buy | 24% Buy |
| Previous Opinion | 24% Sell | 8% Sell | 8% Sell | 8% Sell | 24% Buy |
| Last Month's Opinion | 8% Buy | 88% Buy | 40% Buy | 40% Buy | 48% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.90% since 05/04/26 | -0.87% since 05/04/26 | +1.77% since 05/04/26 | +0.63% since 05/04/26 | -2.98% since 05/04/26 |
| Low | 22.46 on 05/11/26 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 129.00 on 05/08/26 | 55.40 on 05/11/26 |
| High | 25.60 on 05/05/26 | 185.80 on 05/11/26 | 334.19 on 05/11/26 | 136.75 on 05/06/26 | 57.48 on 05/05/26 |
| 1-Month | |||||
| %Chg | -4.41% since 04/10/26 | -10.87% since 04/10/26 | -6.11% since 04/10/26 | -3.94% since 04/10/26 | -5.03% since 04/10/26 |
| Low | 22.46 on 05/11/26 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.64 on 04/27/26 | 55.40 on 05/11/26 |
| High | 27.13 on 05/01/26 | 205.30 on 04/17/26 | 356.90 on 04/20/26 | 141.40 on 04/14/26 | 60.78 on 04/30/26 |
| 3-Month | |||||
| %Chg | +4.65% since 02/11/26 | -11.18% since 02/11/26 | -10.09% since 02/11/26 | -14.30% since 02/11/26 | -7.11% since 02/11/26 |
| Low | 20.62 on 02/27/26 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.64 on 04/27/26 | 55.40 on 05/11/26 |
| High | 27.13 on 05/01/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 156.95 on 02/13/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | -5.72% since 11/11/25 | +2.07% since 11/11/25 | -2.62% since 11/11/25 | +8.94% since 11/11/25 | +14.27% since 11/11/25 |
| Low | 18.80 on 01/20/26 | 174.46 on 11/12/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 27.16 on 12/16/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 910,906 | 283,583,520 | 179,013,520 | 163,009,696 | 114,682,712 |
| Shares Outstanding, K | 39,348 | 1,550,908 | 539,685 | 1,241,222 | 2,042,071 |
| Annual Sales | 726,410,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | 7,030,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 177,380,000 | 15,288,000,000 | 8,618,000,000 | 7,925,000,000 | 11,489,000,000 |
| Last Quarter Net Income | 2,920,000 | 3,080,000,000 | 1,819,000,000 | 2,183,000,000 | 2,677,000,000 |
| 60-Month Beta | 0.32 | 0.26 | 0.44 | 0.31 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.60 on 04/30/26 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 1.58 on 04/30/26 |
| Earnings Date | 08/04/26 | 08/04/26 | 08/04/26 | 08/06/26 | 07/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 14.87 | 19.71 | 14.89 | 16.02 | 9.49 |